Skip to content

Total Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$27.21B-11.6%
Cytokinetics logo
CytokineticsCYTK
$839.47M-12.2%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.25B-2.7%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$940.39M+37.1%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$1.02B+48.1%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$608.21M-29.8%

Other financials

Income statement

See full
Operating income-$54.1M-17.7%
Net income-$49.0M-20.1%
EPS (diluted)-$0.46-7.0%

Balance sheet

See full
Cash & equivalents$33.2M-33.5%
Total debt$3.8M-16.8%
Total equity$493.2M+14.8%
Total assets$518.5M+14.1%

Cash flow

See full
Operating cash flow-$42.5M-12.4%
CapEx$260.0K+491%
Free cash flow-$42.8M-12.9%

Valuation

See full
Market cap$3.96B+61.3%
Enterprise value$3.93B+63.5%

Returns & leverage

See full
Return on equity-38.1%+13.4pp
Debt / equity0.0×
Current ratio22.6×+1.6×

Where this comes from

Reported directly by Edgewise Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s total current assets?
Edgewise Therapeutics, Inc. (EWTX) reported total current assets of $509.79M in Q1 2026.
How has Edgewise Therapeutics, Inc.'s total current assets changed year-over-year?
Edgewise Therapeutics, Inc.'s total current assets increased by 15.0% year-over-year, from $443.18M to $509.79M.
What is the long-term trend for Edgewise Therapeutics, Inc.'s total current assets?
Over 5 years (2020 to 2025), Edgewise Therapeutics, Inc.'s total current assets has grown at a 33.2% compound annual growth rate (CAGR), from $129.65M to $543.39M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.